Fedolen (Calcium Folinate)

Calcium folinate works by providing a reduced form of folic acid that bypasses the inhibition of dihydrofolate reductase. This action restores nucleotide synthesis and mitigates folate deficiency or methotrexate toxicity. It competes with methotrexate for cellular transport, promoting its efflux and reducing its toxic effects, thereby protecting cells from the harmful effects of methotrexate.

The usual dose of Fedolen is determined by a healthcare provider based on the specific condition being treated, the patient's response, and other clinical factors. It is crucial to follow the prescribed dosage and administration instructions provided by the healthcare professional to ensure safe and effective treatment.

The safety of Fedolen during pregnancy or breastfeeding has not been fully established. It should be used during pregnancy only if clearly needed and under the supervision of a healthcare provider. Similarly, breastfeeding mothers should consult their healthcare provider before using Fedolen to ensure the safety of the infant.

To order Fedolen from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will then provide pricing, availability, shipping details, and the necessary import paperwork.

Fedolen is specifically designed to counteract the effects of folic acid antagonists and provide rescue therapy in cases of methotrexate toxicity. Unlike general folate supplements, it provides a reduced form of folic acid that can bypass the inhibition of dihydrofolate reductase, making it more effective in specific clinical scenarios where folate deficiency or toxicity is a concern.

Fedolen should be stored below 25°C, kept in the original pack, and protected from moisture. It is essential to follow the storage instructions provided to maintain the efficacy and safety of the medication. Always handle the medication with care and follow the administration guidelines provided by the healthcare professional.

Fedolen is administered intravenously, typically in a clinical setting under the supervision of a healthcare provider. The dosage and administration schedule are determined based on the specific condition being treated and the patient's response. It is crucial to follow the prescribed administration instructions to ensure safe and effective treatment.

The most serious risks associated with Fedolen include severe allergic reactions, increased ammonia levels in the blood, bone marrow suppression, and severe diarrhea leading to dehydration. Patients should be closely monitored for these adverse effects, and any signs of serious reactions should be reported to a healthcare provider immediately.

Fedolen should not be used by patients with known hypersensitivity to calcium folinate or folic acid. It should be used with caution in patients with renal impairment and only if clearly needed during pregnancy. Always consult a healthcare provider before using Fedolen to ensure it is appropriate for your specific medical condition.